USCACA partner -- The Chinese Journal of Cancer is supported by the International Impact-promoting Program for Chinese Sci-Tech Journals
Recently, the International Impact-promoting Program for Chinese Sci-Tech Journals has released the journal selection results. The Chinese Journal of Cancer (CJC), an English journal sponsored by Sun Yat-sen University Cancer Center, gained type B grant support from this program, with an annual national funding of 1,000,000 RMB for 3 consecutive years.
On the basis of “the Excellent International Sci-Tech Journal Program” sponsored by the Chinese Science and Technology Association in 2012, “the International Impact-promoting Program for Chinese Sci-Tech Journals” is co-sponsored by the Chinese Science and Technology Association, the Ministry of Finance, the Ministry of Education, the State Press and Publication Administration, the Chinese Academy of Sciences, and the Chinese Academy of Engineering. Up to now, this national program provides the strongest financial support to academic journals with the widest journal coverage. It aims to improve the international impact of Chinese Sci-Tech Journals as well as the national academic level and to promote the international communication of outstanding scientific research findings in China.
The CJC was initiated in 1982. In 2010, this journal transferred from a Chinese-language journal into an English-language journal. To make the CJC a top oncologic journal with extensive international impact, we achieved obvious progression on the way of internationalization in recent 4 years. The CJC provides full open access to accelerate the international communication via the journal website, PubMed/Medline, PubMed Center, the Directory of Open Access Journals (DOAJ), and so on. The CJC papers have been browsed by readers from 119 countries, with more than 666,000 downloads for all papers and more than 1,900 downloads for each paper in 2012. Approximately 50% of the CJC-published papers were international submissions from various countries, with the most from the United States. The citations of CJC-published papers are increasing as shown in the Web of Science database: CJC papers have been cited in SCI papers submitted by 282 institutions from 44 countries and regions, which are published in high impact journals, such as Nature Reviews Cancer, Cell, Cancer Cell, Nature Reviews Neurology, Cancer Research, Clinical Cancer Research, Stem Cells, and so on.
In addition to the annual award of the “Top 100 Outstanding Academic Journals of China” for 4 consecutive years and the award of "Excellent International Impact Academic Journal of China" in 2012, the International Impact-promoting Program supporting indicates that the academic value of the CJC is fully approved by the above-mentioned national departments and associations.
Last updated :2013-12-18
Source: Sun Yat-sen University Cancer Center
Written by: Ruan Ji
Translated by: Liu Wei
Edited by: Wang Dongmei
===
USCACA is a partner of the Chinese Journal of Cancer (CJC) . Members of USCACA have organized a number of special issues on important topics including Cancer Drug Discovery, Systems Biology of Cancer, Cancer Autophagy, Mouse Model of Cancer, Signaling pathways of Cancer.
